Cargando…
Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
Autores principales: | Fernandes, Timothy M., Papamatheakis, Demosthenes G., Poch, David S., Kim, Nick H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238818/ https://www.ncbi.nlm.nih.gov/pubmed/32489645 http://dx.doi.org/10.1177/2045894020925761 |
Ejemplares similares
-
Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
por: Horn, Evelyn, et al.
Publicado: (2020) -
Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension
por: Yang, Jenny Z., et al.
Publicado: (2022) -
Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
por: Wu, Sheryl, et al.
Publicado: (2022) -
Evolution of randomized, controlled studies of medical therapy in chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2021) -
Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)